APPLICATION
ANDA209489
TYPE
ANDA
ORIGINAL APPROVAL
2018-07-12
LATEST ACTION
2019-10-10
ROUTE
INTRAVENOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Discontinued
Products
CASPOFUNGIN ACETATEDiscontinued
CASPOFUNGIN ACETATE 70MG/VIAL · POWDER · INTRAVENOUS
CASPOFUNGIN ACETATEDiscontinued
CASPOFUNGIN ACETATE 50MG/VIAL · POWDER · INTRAVENOUS
Approval history
2019-10-10Labeling · Supplement 1 · standardAP
2018-07-12UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.